Andira Pharmaceuticals
PrivateLast Round
Seed Round
Aug 18, 2026
Total Funding Raised
$140,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Andira Pharmaceuticals is a biotechnology company that develops cannabinoid-based therapeutics and medical devices for infection control, post-surgical recovery, and breast cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andira Pharmaceuticals Comparables
Compare Andira Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kane Biotech Inc | 61% | |
| Heron Therapeutics Inc. | 61% | |
| Tetra Bio-Pharma Inc. | 57% | |
Andira Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 18, 2026 | ||||
| Seed Round | Mar 12, 2026 | ||||
| Early Funding | Jun 14, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
| Seed | Nov 23, 2021 |
Key People
Founding team and executive leadership
Andira Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| US Capital Global Securities | Early Funding |
| Mitacs | Grant |
| First Fund | Seed Round, Seed |
| UBC Investment Management | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2026
$100K Seed Round raised.
- Jul 25, 2026
Monthly visitors increased 53% MoM.
Andira Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Andira Pharmaceuticals's valuation, stock price, and market status.